In an in vivo study on a mouse model of esophageal squamous cell carcinoma (ESCC), Yuan et al. (2013) indicated that TSGA10 could serve as a tumor suppressor by activating the p53 or Rb signaling pathways. This evidence concerns the gene TP53 and esophageal squamous cell carcinoma.